PROCEPT BioRobotics Corpo... (PRCT)
NASDAQ: PRCT
· Real-Time Price · USD
38.64
1.14 (3.04%)
At close: Sep 11, 2025, 3:59 PM
38.59
-0.13%
After-hours: Sep 11, 2025, 07:11 PM EDT
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Outside The United States Revenue | 9.6M | 8.87M | 7.85M | 6.16M | 5.68M | 4.34M | 6.05M | 2.78M | 1.6M | 1.47M | 848K | 743K | 869K | 742K | 768K | 481K |
| Outside The United States Revenue Growth | +8.22% | +13.00% | +27.51% | +8.27% | +31.05% | -28.29% | +117.82% | +73.67% | +8.85% | +73.23% | +14.13% | -14.50% | +17.12% | -3.39% | +59.67% | n/a |
| United States Revenue | 69.58M | 60.29M | 60.39M | 52.22M | 47.67M | 40.2M | 68.37M | 32.33M | 14.83M | 8.77M | 10.45M | 9.81M | 8.52M | 7.75M | 5.01M | 5.04M |
| United States Revenue Growth | +15.41% | -0.16% | +15.65% | +9.54% | +18.57% | -41.20% | +111.52% | +118.00% | +69.08% | -16.04% | +6.47% | +15.21% | +9.83% | +54.86% | -0.62% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 56.3M | 55.2M | 48.32M | 42.69M | 40.81M | 39.6M | 36.32M | 32.88M | 32.44M | 30.13M | 26.03M | 24.75M | 19.66M | 18.39M | 16.27M | 12.12M | 12.3M | 10.35M | 9.13M | 7.05M | 7.04M | 7.04M |
| Selling, General, and Administrative Revenue Growth | +2.00% | +14.24% | +13.18% | +4.61% | +3.06% | +9.04% | +10.44% | +1.36% | +7.67% | +15.74% | +5.17% | +25.94% | +6.91% | +12.99% | +34.27% | -1.47% | +18.84% | +13.30% | +29.49% | +0.17% | 0.00% | n/a |
| Research and Development Revenue | 17.63M | 16.4M | 15.07M | 16.65M | 16.23M | 13.08M | 13.18M | 11.6M | 11.61M | 10.74M | 9.68M | 7.58M | 6.71M | 5.01M | 5.08M | 4.92M | 4.48M | 4.52M | 4.54M | 3.89M | 3.92M | 3.92M |
| Research and Development Revenue Growth | +7.50% | +8.87% | -9.50% | +2.56% | +24.06% | -0.71% | +13.60% | -0.11% | +8.16% | +10.90% | +27.70% | +13.06% | +33.83% | -1.28% | +3.19% | +9.90% | -1.02% | -0.46% | +16.70% | -0.68% | 0.00% | n/a |